Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled trial of Jiuwei Shufeng Pingchuan Granules in chronic persistent bronchial asthma (wind-asthma pattern)
CTR20253811Phase 3Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Dec 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Jiuwei Shufeng Pingchuan in asthma, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Dec 2025; status: active.
02
Drugs
Jiuwei Shufeng Pingchuan
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20253811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253811.